2018
DOI: 10.1371/journal.pone.0201788
|View full text |Cite
|
Sign up to set email alerts
|

A novel recombinant human plasminogen activator: Efficient expression and hereditary stability in transgenic goats and in vitro thrombolytic bioactivity in the milk of transgenic goats

Abstract: BackgroundThromboses is a rapidly growing medical problem worldwide. Low-cost, high-scale production of thrombotic drugs is needed to meet the demand. The production of biomolecules in transgenic animals might help address this issue. To our knowledge, the expression of recombinant human plasminogen activator (rhPA) in goat mammary glands has never been reported before.MethodsWe constructed a mammary gland–specific expression vector, BLC14/rhPA, which encodes only the essential K2 fibrin-binding and P domains … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 36 publications
(61 reference statements)
0
6
0
Order By: Relevance
“…This high pricing has limited the application of the recombinant rPA, especially in the developing and third-world countries. To overcome this issue, alternative production systems have been tested: Chinese hamster ovary cells (Davami et al, 2010), insect cells (Aflakiyan et al, 2013), yeast (Shu-Guang et al, 2006), transgenic animals (He et al, 2018), and transgenic plants (Zhang et al, 2008; Nasab et al, 2016; Hidalgo et al, 2017). However, most of these were not found to be appropriate.…”
Section: Introductionmentioning
confidence: 99%
“…This high pricing has limited the application of the recombinant rPA, especially in the developing and third-world countries. To overcome this issue, alternative production systems have been tested: Chinese hamster ovary cells (Davami et al, 2010), insect cells (Aflakiyan et al, 2013), yeast (Shu-Guang et al, 2006), transgenic animals (He et al, 2018), and transgenic plants (Zhang et al, 2008; Nasab et al, 2016; Hidalgo et al, 2017). However, most of these were not found to be appropriate.…”
Section: Introductionmentioning
confidence: 99%
“…These two medical proteins play an important role in clinic and have been widely studied and applied by scientists at home and abroad. Our team has previously produced tPA and LTF transgenic cloned goats with high expression levels using SCNT and successfully obtained these two foreign proteins with superior performance (He et al., 2018; Yuan et al., 2017). Therefore, choosing these two valuable gene expression vectors as research objects has a certain research foundation.…”
Section: Discussionmentioning
confidence: 99%
“…Animal cloning by somatic cell nuclear transfer (SCNT), which avoids the sexual reproduction pathway, offers the opportunity to obtain monogenetic offspring derived not only from adult animals of high genetic merit but also from genetically transformed (transgenic) specimens. Over the last 24 years, intra- and interspecies cloning via SCNT resulted in a fairly large number of transgenic and non-transgenic offspring, not only in various species or infertile interspecific hybrids (bastards) of domesticated animals, such as cattle [ 8 , 9 , 10 , 11 , 12 , 13 , 14 ]; goats [ 6 , 15 , 16 , 17 , 18 , 19 , 20 ]; sheep [ 21 , 22 , 23 , 24 , 25 , 26 ]; pigs [ 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ]; equids—domestic horses [ 42 , 43 , 44 , 45 , 46 ] and mules [ 47 ]; water buffaloes—Chinese swamp buffaloes [ 48 , 49 ] and Indian river/riverine buffaloes [ 50 , ...…”
Section: Biotechnological Possibilities Of Applying the Techniquesmentioning
confidence: 99%